Veterinary Assistive Reproduction Technology Market To Reach $4.27 Billion By 2030

The global veterinary assistive reproduction technology market size is expected to reach USD 4.27 billion by 2030, registering a CAGR of 7.42% from 2024 to 2030, according to a new report by Grand View Research, Inc. The key factors driving market growth include increasing advancements in veterinary assistive reproduction technologies, R&D activities, demand for animal protein, and a growing focus on improving animal breeding outcomes. The cost-effectiveness of artificial insemination is further influencing adoption rates in the livestock industry, where improved reproductive outcomes directly impact profitability. According to a study published in June 2019 in the National Library of Medicine Journal, embryo production with sexed semen (X-sorted) and follicular growth-stimulated (FGS) oocytes bred female calves more efficiently than other embryo sexing methods.

The COVID-19 pandemic and African Swine Fever notably impacted the market with slow growth, supply chain challenges, and operational hurdles. These factors affected certain markets (e.g. China) during 2022-23. However, as the underlying drivers remain unchanged, the market is expected to grow at a significant CAGR over the forecast period. The market dynamics also vary across regions, with different countries experiencing varying levels of adoption based on factors, such as animal population, economic conditions, cultural attitudes towards pets & livestock, and regulatory environments. Moreover, advancements in reproductive technologies have led to improved procedure success rates. This increased efficiency is expected to drive the adoption of veterinary assistive reproduction technologies in the near future.

The livestock segment accounted for the highest revenue share in 2023 and is anticipated to maintain its dominance over the forecast period. It is because the livestock sector has been adopting reproductive technologies to enhance breeding efficiency, improve the genetic traits of livestock, and boost agricultural productivity for a long time. Furthermore, the potential of various veterinary assistive reproduction technologies is projected to propel awareness, demand, and adoption of the same in the near future. For instance, the Brazilian Agricultural Research Corporation (Embrapa) estimated the potential of reproduction techniques with artificial insemination facilitating the obtention of a calf per year. Classic Embryo Transfer (ET) was estimated to produce one calf monthly, while IVF to breed one calf per week.

Veterinary Assistive Reproduction Technology Market Report Highlights

• Based on product, the normal semen segment dominated the industry in 2023, while the sexed semen segment is expected to grow at the fastest CAGR of over 8.0% from 2024 to 2030
• The increasing awareness and uptake of veterinary assistive reproduction technologies are crucial factors contributing to market growth
• In terms of distribution channel, the private segment held the highest revenue share in 2023 and is also expected to grow at the fastest CAGR from 2024 to 2030
• The AI conception method segment led the industry in 2023. However, the IVF segment is estimated to register the fastest CAGR from 2024 to 2030
• The bovine animal type segment accounted for the highest revenue share in 2023. The other animals segment is expected to grow at the fastest CAGR from 2024 to 2030
• Ongoing R&D efforts focus on refining existing technologies, comparing existing technologies, and exploring new methods to enhance reproductive outcomes to address specific challenges in different animal species. It is estimated to support the segment growth
• In 2023, North America accounted for the highest revenue share. Asia Pacific is anticipated to register the fastest CAGR from 2024 to 2030

Curious about the Veterinary Assistive Reproduction Technology Market? Download your FREE sample copy now and get a sneak peek into the latest insights and trends.

Veterinary Assistive Reproduction Technology Market Segmentation

Grand View Research has segmented the global veterinary assistive reproduction technology market based on product, animal type, distribution channel, conception method, and region:

Veterinary Assistive Reproduction Technology Animal Type Outlook (Revenue, USD Million, 2018 - 2030)

• Bovine
• Swine
• Ovine
• Caprine
• Equine
• Other Animals

Veterinary Assistive Reproduction Technology Product Outlook (Revenue, USD Million, 2018 - 2030)

• Normal Semen
• Sexed Semen

Veterinary Assistive Reproduction Technology Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Private
• Public

Veterinary Assistive Reproduction Technology Conception Method Outlook (Revenue, USD Million, 2018 - 2030)

• Artificial Insemination
• Embryo Transfer (MOET)
• IVF

Veterinary Assistive Reproduction Technology Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Norway
  • Denmark
  • Sweden
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Key Players in Veterinary Assistive Reproduction Technology Market

• Genus Plc
• URUS Group LP
• CRV
• SEMEX
• Select Sires Inc.
• Swine Genetics International
• National Dairy Development Board
• STgenetics
• VikingGenetics
• Geno SA

Order a free sample PDF of the Veterinary Assistive Reproduction Technology Market Intelligence Study, published by Grand View Research.